Your Basket 0

Search Results for:
Catalogue No Partner Description Species Application
HY-100711-1mg MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-100711-10mg MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-100711-100ug MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-100711-250ug MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-100711-5mg MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-100711-500ug MedChemexpress LLC Prodigiosin [CAS 82-89-3] Cancer-programmed cell death
HY-D0815-10mg MedChemexpress LLC Propidium (Iodide) [CAS 25535-16-4] COVID-19-immunoregulation
HY-D0815-100mg MedChemexpress LLC Propidium (Iodide) [CAS 25535-16-4] COVID-19-immunoregulation
HY-D0815-5mg MedChemexpress LLC Propidium (Iodide) [CAS 25535-16-4] COVID-19-immunoregulation
HY-D0815-50mg MedChemexpress LLC Propidium (Iodide) [CAS 25535-16-4] COVID-19-immunoregulation
HY-D0815-500mg MedChemexpress LLC Propidium (Iodide) [CAS 25535-16-4] COVID-19-immunoregulation
HY-112697-10mg MedChemexpress LLC Rhodamine B isothiocyanate [CAS 36877-69-7]
HY-112697-100mg MedChemexpress LLC Rhodamine B isothiocyanate [CAS 36877-69-7]
HY-112697-25mg MedChemexpress LLC Rhodamine B isothiocyanate [CAS 36877-69-7]
HY-112697-5mg MedChemexpress LLC Rhodamine B isothiocyanate [CAS 36877-69-7]
HY-112697-50mg MedChemexpress LLC Rhodamine B isothiocyanate [CAS 36877-69-7]
HY-D1533-10mg MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4]
HY-D1533-100mg MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4]
HY-D1533-25mg MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4]
HY-D1533-5mg MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4]
HY-D1533-50mg MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4]
HY-D1533-1mL MedChemexpress LLC RhoNox-1 [CAS 1447815-38-4] (10mM in DMSO)
HY-P71313-10ug MedChemexpress LLC Siglec-8, Human (HEK293, His)
HY-P71313-50ug MedChemexpress LLC Siglec-8, Human (HEK293, His)
HY-14602-1g MedChemexpress LLC Tramiprosate [CAS 3687-18-1] Cancer-programmed cell death